We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
(+11%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 2 |
Norwegian Cruise Line
NCLH
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 5 |
Steel Dynamics
STLD
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$176M |
| 2 |
Coca-Cola
KO
|
+$151M |
| 3 |
Broadcom
AVGO
|
+$146M |
| 4 |
Microsoft
MSFT
|
+$140M |
| 5 |
ExxonMobil
XOM
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.93% |
| 2 | Industrials | 11.65% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 11.56% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Citigroup
C
$222B
| $16.6M | 0.09% |
367,378
-1,036,059
| -74% | -$47.1M |
|
327
KE Holdings
BEKE
$16.8B
| $16.6M | 0.09% |
+1,185,675
| New | +$16.5M |
|
328
Genmab
GMAB
$17.7B
| $16.5M | 0.09% |
+389,081
| New | +$16M |
|
329
PUT
Abbott
ABT
$180B
| $16.5M | 0.09% |
+150,000
| New | +$15.5M |
|
330
First Horizon
FHN
$12.1B
| $16.4M | 0.09% |
670,366
+562,552
| +522% | +$13.6M |
|
331
Lennox International
LII
$18.8B
| $16.4M | 0.09% |
+68,513
| New | +$16.8M |
|
332
UnitedHealth
UNH
$382B
| $16.4M | 0.09% |
30,897
-85,343
| -73% | -$45.2M |
|
333
Trex
TREX
$4.51B
| $16.3M | 0.09% |
384,186
+185,951
| +94% | +$8.44M |
|
334
National Fuel Gas
NFG
$7.84B
| $16.1M | 0.09% |
255,011
-62,767
| -20% | -$4.04M |
|
335
iShares TIPS Bond ETF
TIP
$14.5B
| $16.1M | 0.09% |
151,016
+141,511
| +1,489% | +$15.1M |
|
336
Hasbro
HAS
$12.6B
| $16.1M | 0.09% |
+263,286
| New | +$16.4M |
|
337
Extra Space Storage
EXR
$31.2B
| $16.1M | 0.09% |
109,066
+37,670
| +53% | +$6.02M |
|
338
VICI Properties
VICI
$29.4B
| $16M | 0.09% |
+495,216
| New | +$15.9M |
|
339
ASML
ASML
$675B
| $16M | 0.09% |
29,280
-12,161
| -29% | -$6.37M |
|
340
Travel + Leisure Co
TNL
$4.54B
| $16M | 0.09% |
439,004
-124,946
| -22% | -$4.68M |
|
|
LTHM
341
DELISTED
Livent Corporation
LTHM
| $16M | 0.09% |
+804,202
| New | +$22M |
|
342
Landstar System
LSTR
$6.8B
| $15.8M | 0.08% |
+96,803
| New | +$15.5M |
|
343
Hartford Financial Services
HIG
$38.5B
| $15.6M | 0.08% |
205,636
-170,441
| -45% | -$12.3M |
|
344
Cullen/Frost Bankers
CFR
$10.3B
| $15.6M | 0.08% |
+116,549
| New | +$16.6M |
|
345
Wingstop
WING
$3.68B
| $15.5M | 0.08% |
112,917
+101,683
| +905% | +$15M |
|
346
HEICO Corp Class A
HEI.A
$35.4B
| $15.5M | 0.08% |
129,331
+67,923
| +111% | +$8.29M |
|
347
Bank OZK
OZK
$5.49B
| $15.5M | 0.08% |
+386,801
| New | +$16.6M |
|
348
Nike
NKE
$61.9B
| $15.5M | 0.08% |
132,087
-371,195
| -74% | -$37.4M |
|
349
Canadian Pacific Kansas City
CP
$82B
| $15.4M | 0.08% |
206,990
-59,723
| -22% | -$4.49M |
|
350
Wendy's
WEN
$1.33B
| $15.4M | 0.08% |
680,871
+609,701
| +857% | +$13M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review
As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
- Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
- Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
- Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.